Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride 1 mg/day for five years effectively improves hair growth and slows hair loss in men with male pattern baldness, and is safe for long-term use.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Skin reactions from cancer treatments might predict how well the treatments work.

Foam corticosteroid covers as well as traditional forms.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Cannabinoids may help treat various skin conditions.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Non-coding RNAs could help detect and treat radiation damage.